{"disease":{"id":"idiopathic-inflammatory-myositis-iim","name":"idiopathic inflammatory myositis iim"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06308978","title":"A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":244,"lead_sponsor_name":"Fate Therapeutics","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}